Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4(+) lymphocyte proliferation

Serine leucocyte proteinase inhibitor (SLPI) is the main serine proteinase inhibitor produced by epithelial cells and has been shown to be a pleiotropic molecule with anti-inflammatory and microbicidal activities. However, the role of SLPI on the adaptive immune response is not well established. The...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Guerrieri, Diego, Tateosian, Nancy L, Maffía, Paulo C, Reiteri, Romina M, Amiano, Nicolás O, Costa, María J, Villalonga, Ximena, Sanchez, Mercedes L, Estein, Silvia M, Garcia, Verónica E, Sallenave, Jean-Michel, Chuluyan, Héctor E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2011
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3143355/
https://ncbi.nlm.nih.gov/pubmed/21574992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2567.2011.03451.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak